Matthew Bolden

Kinsa

A 2021 Fast Company Most Innovative Company, Kinsa is an insights solutions business using data and advanced analytics to track and forecast the spread of illness and predict corresponding demand for healthcare products and services. For products in highly volatile categories such as cough, cold, flu, nasal, allergy, Covid, and disinfectants, Kinsa helps brands and retailers: Reduce out-of-stocks Assess risk and plan more effectively Enhance marketing & media effectiveness to where and when people need their products For hospitals, health systems and health insurers, Kinsa helps predict when & where to expect surges in hospitalizations or ED visits, and what to proactively message to keep high risk people healthy. Kinsa aggregates data from more than 30 sources and, most importantly, collects the "missing ingredient" data from a proprietary network of millions of users to accurately detect and forecast spreading infectious illness. To capture hyperlocal illness data before someone ever visits the doctor or enters the healthcare system, Kinsa invented a new category of products — smart thermometers — that along with its medical guidance mobile apps and email / text alerts enables Kinsa to communicate with households at symptom onset. Industry's use of these forecasts helps Kinsa achieve its mission of helping families and communities predict, prepare for, and prevent the spread of illness. The team at Kinsa brings together the best of technology, data analytics, healthcare, and design. We're backed by Kleiner Perkins, GSR Ventures, FirstMark Capital and others, and are led by some of the top public health, software, hardware, data science, and mobile app minds in the business. Our founders and executives have built successful ventures, created best selling mobile apps and smartphone-connected devices, and led programs that have put millions of people onto life-saving treatment.